文献速递免疫规划传染病防控与疫情报告

皮内接种EV71/CA16二价灭活疫苗在小鼠中的免疫效果

Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
PubMed 文献 · Vaccine · 2020-12-17

本研究开发了EV71/CA16二价灭活疫苗,经皮内途径免疫BALB/c小鼠。局部上皮组织Q-RT-PCR显示固有免疫激活,包括趋化因子、干扰素和CD分子mRNA上调;成年小鼠间隔28天两次免疫后产生中和抗体和特异性T细胞应答,并使子代小鼠获得抵御病毒攻击的能力。

要点

  • 皮内接种二价EV71/CA16灭活疫苗可激活局部固有免疫信号分子mRNA表达。
  • 间隔28天两次免疫诱导成年小鼠产生中和抗体和特异性T细胞应答。
  • 免疫母鼠的子代小鼠可抵御病毒攻击,提示保护性免疫可传递。

核心结论

  • 皮内途径接种该二价EV71/CA16灭活疫苗可诱导针对EV71和CA16感染的有效免疫。

研究设计与样本

  • 在BALB/c小鼠中经皮内途径接种二价灭活EV71/CA16疫苗并进行免疫评价。
  • 采用Q-RT-PCR检测接种局部上皮组织中免疫信号分子mRNA。
  • 成年小鼠间隔28天两次免疫,并观察子代小鼠对病毒攻击的抵御能力。

主要发现

  • 接种局部上皮组织中免疫相关趋化因子、干扰素和CD分子mRNA上调,提示固有免疫激活。
  • 成年小鼠两次免疫后产生中和抗体和特异性T细胞应答。
  • 免疫母鼠的子代小鼠能够抵御病毒攻击。

临床怎么用

  • 为EV71/CA16二价灭活疫苗经皮内途径免疫的后续研究提供小鼠实验依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human hand, foot, and mouth disease (HFMD), an important infectious disease in children, is caused mainly by enterovirus 71 (EV71) and coxsackievirus A16 (CA16). In this study, a bivalent inactivated EV71/CA16 vaccine is developed and evaluated in immunized BALB/c mice injected through the intradermal route. Q-RT-PCR detection of the mRNA of immune signal molecules in local epithelial tissues inoculated with the vaccine indicates activation of innate immunity, which includes upregulation of immune-related chemokines, interferons and CD molecules. Further, the finding that neutralizing antibodies and specific T cellular responses were elicited in adult mice after two immunizations with the vaccine at a 28-day interval, which endowed offspring mice to defend a viral challenge, suggests the successful induction of specific protective antiviral immunity. All these data suggest that immunization with this bivalent EV71/CA16 vaccine via the intradermal route elicits effective immunity against EV71 and CA16 infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fan S, Liao Y, Jiang G, et al. Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally. Vaccine. 2020. PMID: 33342637. doi:10.1016/j.vaccine.2020.11.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。